These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15232833)

  • 1. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Nishikimi T; Matsuoka H
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232833
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Januzzi JL; Maisel AS
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15226236
    [No Abstract]   [Full Text] [Related]  

  • 3. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Troughton RW; Richards AM; Yandle TG; Nicholls G
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232832
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 5. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
    Morello AM; Januzzi JL
    Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH; Apple FS; Ravkilde J; Wu AH;
    Circulation; 2007 Jul; 116(5):e99-109. PubMed ID: 17630410
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of the brain natriuretic peptide in heart failure management.
    Kalsmith BM
    Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
    Lindstedt G
    Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure.
    Shapiro BP; Chen HH; Burnett JC; Redfield MM
    Mayo Clin Proc; 2003 Apr; 78(4):481-6. PubMed ID: 12683700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

  • 13. B-type natriuretic peptide and the stressed heart.
    Nohria A; Givertz MM
    J Am Coll Cardiol; 2006 Feb; 47(4):749-51. PubMed ID: 16487839
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers in heart failure. Does prognostic utility translate to clinical futility?
    Maisel A
    J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease.
    Sullivan DR; West M; Jeremy R
    Heart Lung Circ; 2005 Jun; 14(2):78-84. PubMed ID: 16352258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.
    O'Donoghue M; Januzzi JL
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):487-96. PubMed ID: 15889976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain natriuretic peptide in the contemporary management of congestive heart failure.
    Wasywich CA; Whalley GA; Doughty RN
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):71-84. PubMed ID: 15723576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide in heart failure and beyond.
    Mowla MM; Bustami BB
    Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A basic guide to understanding plasma B-type natriuretic peptide in the diagnosis of congestive heart failure.
    Kreiger G
    Medsurg Nurs; 2007 Apr; 16(2):75-8; quiz 79. PubMed ID: 17547263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suspected heart failure: how important is the BNP-testing for the general practitioner?].
    Pfister R; Erdmann E
    MMW Fortschr Med; 2009 Apr; 151(15):31-2. PubMed ID: 19728678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.